CN104987325A - 一种伏立康唑的制备方法 - Google Patents
一种伏立康唑的制备方法 Download PDFInfo
- Publication number
- CN104987325A CN104987325A CN201510375647.7A CN201510375647A CN104987325A CN 104987325 A CN104987325 A CN 104987325A CN 201510375647 A CN201510375647 A CN 201510375647A CN 104987325 A CN104987325 A CN 104987325A
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- preparation
- compd
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WUOSZKITCSIVHE-UHFFFAOYSA-N CC(C(CN1N=CNC1)c(c(F)c1)ccc1F)c(ncnc1)c1F Chemical compound CC(C(CN1N=CNC1)c(c(F)c1)ccc1F)c(ncnc1)c1F WUOSZKITCSIVHE-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510375647.7A CN104987325B (zh) | 2015-06-30 | 2015-06-30 | 一种伏立康唑的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510375647.7A CN104987325B (zh) | 2015-06-30 | 2015-06-30 | 一种伏立康唑的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104987325A true CN104987325A (zh) | 2015-10-21 |
CN104987325B CN104987325B (zh) | 2017-03-29 |
Family
ID=54299245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510375647.7A Active CN104987325B (zh) | 2015-06-30 | 2015-06-30 | 一种伏立康唑的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104987325B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110305113A (zh) * | 2019-07-05 | 2019-10-08 | 镇江市第四人民医院(镇江市妇幼保健院) | 一种伏立康唑杂质b的合成方法 |
CN111704606A (zh) * | 2020-06-11 | 2020-09-25 | 广东隆赋药业股份有限公司 | 一种伏立康唑中间体的制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1053787A (zh) * | 1990-02-02 | 1991-08-14 | 美国辉瑞有限公司 | 三唑类抗真菌剂 |
WO2010095145A1 (en) * | 2009-02-17 | 2010-08-26 | Glenmark Generics Limited | Process for the preparation of voriconazole |
CN102190628A (zh) * | 2010-03-03 | 2011-09-21 | 浙江海翔药业股份有限公司 | 一种5-氟-6-乙基-4-羟基嘧啶中间体及伏立康唑的制备方法 |
CN103788073A (zh) * | 2013-12-18 | 2014-05-14 | 北京华禧联合科技发展有限公司 | 一种制备伏立康唑关键中间体的新方法 |
CN104744441A (zh) * | 2013-12-26 | 2015-07-01 | 李磊 | 一种伏立康唑的制备方法 |
-
2015
- 2015-06-30 CN CN201510375647.7A patent/CN104987325B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1053787A (zh) * | 1990-02-02 | 1991-08-14 | 美国辉瑞有限公司 | 三唑类抗真菌剂 |
WO2010095145A1 (en) * | 2009-02-17 | 2010-08-26 | Glenmark Generics Limited | Process for the preparation of voriconazole |
CN102190628A (zh) * | 2010-03-03 | 2011-09-21 | 浙江海翔药业股份有限公司 | 一种5-氟-6-乙基-4-羟基嘧啶中间体及伏立康唑的制备方法 |
CN103788073A (zh) * | 2013-12-18 | 2014-05-14 | 北京华禧联合科技发展有限公司 | 一种制备伏立康唑关键中间体的新方法 |
CN104744441A (zh) * | 2013-12-26 | 2015-07-01 | 李磊 | 一种伏立康唑的制备方法 |
Non-Patent Citations (1)
Title |
---|
周伟澄 等: "唑类抗真菌药的合成评述", 《中国医药工业杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110305113A (zh) * | 2019-07-05 | 2019-10-08 | 镇江市第四人民医院(镇江市妇幼保健院) | 一种伏立康唑杂质b的合成方法 |
CN111704606A (zh) * | 2020-06-11 | 2020-09-25 | 广东隆赋药业股份有限公司 | 一种伏立康唑中间体的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104987325B (zh) | 2017-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108424388B (zh) | 一种慢性贫血药物的制备方法 | |
CN108033922B (zh) | 一种3-酰基喹喔啉酮衍生物的制备方法 | |
CN107936029B (zh) | 一种合成瑞博西尼的方法 | |
CN105348172B (zh) | (s)‑1‑(4‑甲氧基‑3‑乙氧基)苯基‑2‑甲磺酰基乙胺的制备及阿普斯特的制备方法 | |
CN108623456B (zh) | 丁苯酞及其药物中间体的制备方法 | |
CN101486753A (zh) | 一种非那雄胺新的合成方法 | |
CN103896855A (zh) | 一种4-(1-溴代乙基)-5-氟-6-氯嘧啶的合成方法 | |
Srivastava et al. | Direct sulfonylation of Baylis–Hillman alcohols and diarylmethanols with TosMIC in ionic liquid-[Hmim] HSO4: an unexpected reaction | |
CN104987325A (zh) | 一种伏立康唑的制备方法 | |
CN104892614A (zh) | 一种6H-异吲哚并[2,1-α]吲哚-6-酮衍生物的合成方法 | |
CN102491953A (zh) | 一种合成氟苯尼考中间体rt0131的方法 | |
CN110016023B (zh) | 一种帕博西尼的简便制备方法 | |
CN103102264B (zh) | 一类水杨酸类化合物的制备方法 | |
CN105968040A (zh) | 一种雷迪帕韦中间体的制备方法 | |
CN106317024A (zh) | 克唑替尼中间体、制备方法以及克唑替尼的制备方法 | |
CN113292501A (zh) | 一种多菌灵的制备方法 | |
CN106883227A (zh) | 通过麦角菌发酵废料制备麦角新碱的方法 | |
CN105085255B (zh) | 一种咪唑啉酮类除草剂中间体2‑烷氧基‑3‑氧代‑丁二酸二酯的合成工艺 | |
WO2022097115A1 (en) | An improved process for preparation of prohexadione and its calcium salt | |
CN104557877A (zh) | 一种阿伐那非中间体及其制备方法和应用 | |
CN108299466B (zh) | 一种改进的度鲁特韦合成方法 | |
CN113773182A (zh) | 一种合成6,8-二氯辛酸酯的方法 | |
CN103554041B (zh) | 一种制备阿那曲唑的合成工艺 | |
CN102942578B (zh) | 1-氧杂头孢菌素-3-环氧亚甲基衍生物的制备方法及其在氧头孢制备中的应用 | |
CN102079720B (zh) | 一种制备1-苄基-4-哌啶甲醛的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160905 Address after: No. 9 Qixia Xianlin Avenue District of Nanjing City, Jiangsu province 210049 Applicant after: Nanjing Hailing Pharmaceutical Co., Ltd. of Yangtze River Pharmaceutical Group Applicant after: Nanjing Hailing Chinese Medicine Pharmaceutical Technology Research Co., Ltd. Applicant after: Jiangsu Haici Biological Pharmaceutical Co., Ltd. of Yangtze River Pharmaceutical Group Address before: No. 9 Qixia Xianlin Avenue District of Nanjing City, Jiangsu province 210049 Applicant before: Nanjing Hailing Pharmaceutical Co., Ltd. of Yangtze River Pharmaceutical Group Applicant before: Nanjing Hailing Chinese Medicine Pharmaceutical Technology Research Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |